Browsing Tag
Roundup
4 posts
Bayer shares jump 5% as Nubeqa nears €1bn a quarter. Is the Monsanto shadow finally shrinking?
Bayer raised its 2026 profit outlook after pharmaceuticals delivered stronger sales and margins, led by rapid Nubeqa and Kerendia growth, but negative free cash flow, legacy product declines and the unresolved $7.25 billion Roundup settlement show why the turnaround remains incomplete.
Why Bayer moved its U.S. Roundup and glyphosate operations into Ruveon LLC
Find out how Bayer’s Ruveon launch could reshape U.S. glyphosate pricing, Roundup strategy, farmer costs and legal risk.
Bayer (ETR: BAYN) Q1 beat lifts shares as Supreme Court Roundup ruling looms
Bayer just beat Q1 consensus by 19%. But the bigger question is whether the Supreme Court hands the company its Roundup endgame in six weeks.
Is Bayer’s Roundup litigation strategy finally gaining legal traction with U.S. Supreme Court review?
Bayer's Roundup strategy just got a Supreme Court boost. Find out what the Durnell review could mean for tort law, federal preemption, and investor sentiment.